hit counter
Compugen Ltd. (CGEN) Stock News Sentiment & Price - Sentifly
CGEN - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Compugen Ltd. (CGEN)

Israel
Biotechnology
NASDAQ
CGEN Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
CGEN Latest news
PRNewsWire
Neutral
Compugen to Release Third Quarter 2021 Results on Friday, November 12, 2021
2021-10-26 07:00

HOLON, Israel, Oct. 26, 2021 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, announced today that the Company will release its third quarter 2021 financial results on Friday, November 12, 2021, before the U.S. financial markets open.

PRNewsWire
Neutral
Compugen Announces Milestone Payment from AstraZeneca Triggered by First Patient Dosed with TIGIT Bispecific Derived from COM902
2021-10-04 07:00

HOLON, Israel, Oct. 4, 2021 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that Compugen is entitled to receive a $6 million milestone payment from AstraZeneca (LSE: AZN) (STO: AZN) (Nasdaq: AZN) triggered by the dosing of the first patient in a Phase 1/2 study evaluating AZD2936, a TIGIT/PD-1 bispecific antibody, in patients with advanced or metastatic non-small cell lung cancer.

PRNewsWire
Neutral
Compugen To Present Clinical Data from anti-TIGIT COM902 Monotherapy and Triple Combination Dose Escalation Studies at SITC 2021
2021-10-01 08:05

HOLON, Israel, Oct. 1, 2021 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that new clinical and preclinical data will be presented at the 36th Annual Meeting of the Society for Immunotherapy of Cancer, which will be held on November 10-14, 2021.

PRNewsWire
Neutral
Compugen to Present at the Cantor Global Healthcare Conference
2021-09-14 09:00

HOLON, Israel, Sept. 14, 2021 /PRNewswire/ -- Compugen Ltd.

PRNewsWire
Neutral
Compugen to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
2021-08-26 07:00

HOLON, Israel, Aug. 26, 2021 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, today announced that management will present at the Morgan Stanley 19th Annual Global Healthcare Conference (virtual), on Thursday, September 9, 2021 at 11:00 am ET.

The Motley Fool
Positive
This Unknown Biotech Has a Secret Weapon for Outsized Returns
2021-08-21 07:19

Bio-Rad's equity position in a German pharma company is an asset many investors may not realize.

Benzinga
Positive
Compugen's Out-Licensed Lung Cancer Candidate Enters Human Trial
2021-08-19 09:58

AstraZeneca Plc's (NASDAQ: AZN) bispecific antibody derived from Compugen Ltd's (NASDAQ: CGEN) COM902 will advance into clinical development.  AstraZeneca plans to initiate a Phase 1/2 study evaluating AZD2936, a TIGIT/PD-1 bispecific antibody, in patients with advanced or metastatic non-small cell lung cancer.

PRNewsWire
Neutral
Compugen Announces Bispecific Antibody Derived from COM902 to Enter Clinical Development
2021-08-19 07:00

HOLON, Israel , Aug. 19, 2021  /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a leader in predictive discovery and development of first-in-class therapeutics for cancer immunotherapy, today announced that a bispecific antibody of AstraZeneca derived from COM902, Compugen's high affinity anti-TIGIT antibody, will advance into clinical development.

The Motley Fool
Positive
Why Compugen Stock Is Rising Again Today
2021-07-29 11:41

Momentum is carrying over from the company's second-quarter update on Wednesday.

Seeking Alpha
Neutral
Compugen Ltd (CGEN) CEO Anat Cohen-Dayag on Q2 2021 Results - Earnings Call Transcript
2021-07-28 15:10

Compugen Ltd (CGEN) CEO Anat Cohen-Dayag on Q2 2021 Results - Earnings Call Transcript

Loading more news...